Albuquerque, NM and San Diego, CA, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Exagen, a leader in autoimmune life sciences, today announced that it will present at the Cowen and Company 39th Annual Health Care Conference being held March 11-13, in Boston, MA.
Ron Rocca, President and CEO, will present an overview of the company, including the patented cell-bound complement activation products (CB-CAPs) technology and other recent advances for the AVISE brand of testing on Tuesday, March 12 at 3:00 p.m. ET.
About Exagen Inc.
Exagen is a commercial stage life sciences company that is patient-focused and discovery driven. We serve patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. By leveraging our patented and validated technologies we can help get to the real cause of a patient’s symptoms and guide their journey to improved health. For more information visit, www.exagen.com or follow us on Facebook, Twitter, YouTube, LinkedIn, or Instagram.
Exagen Inc. to Present at the Cowen and Company 39th Annual Health Care Conference 2019
Trusted Partner to the rheumatology specialty to present at upcoming health care conference
| Source: Exagen Diagnostics, Inc.
Recommended Reading
-
Third Quarter Revenue Grew 7% to $18.4 Million Year-to-Date Revenue Grew 11%, Net Loss Reduced by 12% and Adjusted EBITDA Loss Improved by Over 30% CARLSBAD, Calif., Nov. 10, 2026 ...
Read More -
Exagen will participate in the Canaccord Genuity MedTech & Diagnostics Conference November 11 and the Craig-Hallum Alpha Select Conference November 17
Read More